医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
11期
42-42
,共1页
黛力新%甘淮大枣汤%躯体性焦虑
黛力新%甘淮大棘湯%軀體性焦慮
대력신%감회대조탕%구체성초필
Flupentixol&Melitracen Tablets%Ganhuaidazao%Somatization disorder
目的探讨黛力新与甘淮大枣汤治疗躯体性焦虑的疗效和副反应。方法66例患者按就诊先后随机分为治疗组和对照组，分别进行黛力新与甘淮大枣汤治疗4w，于治疗前及治疗后分别进行汉密顿焦虑量表（HAMA）、四级临床疗效及安全性的评估。结果两组总有效率分别为82.25%、54.83%，两组间疗效差异有显著性（值<0.01），甘淮大枣汤组未见明显不良反应，黛力新组不良反应发生率为2.01%，主要为轻度恶心。结论黛力新治疗躯体性焦虑疗效较好，副作用少。
目的探討黛力新與甘淮大棘湯治療軀體性焦慮的療效和副反應。方法66例患者按就診先後隨機分為治療組和對照組，分彆進行黛力新與甘淮大棘湯治療4w，于治療前及治療後分彆進行漢密頓焦慮量錶（HAMA）、四級臨床療效及安全性的評估。結果兩組總有效率分彆為82.25%、54.83%，兩組間療效差異有顯著性（值<0.01），甘淮大棘湯組未見明顯不良反應，黛力新組不良反應髮生率為2.01%，主要為輕度噁心。結論黛力新治療軀體性焦慮療效較好，副作用少。
목적탐토대력신여감회대조탕치료구체성초필적료효화부반응。방법66례환자안취진선후수궤분위치료조화대조조，분별진행대력신여감회대조탕치료4w，우치료전급치료후분별진행한밀돈초필량표（HAMA）、사급림상료효급안전성적평고。결과량조총유효솔분별위82.25%、54.83%，량조간료효차이유현저성（치<0.01），감회대조탕조미견명현불량반응，대력신조불량반응발생솔위2.01%，주요위경도악심。결론대력신치료구체성초필료효교호，부작용소。
Objective To explore the therapeutic ef icacy and side-ef ects of Flupentixol and Melitracen Tablets for somatization disorder compared with ganhuaidazao. Methods 66 patients were divided at random into therapy group treated with Flupentixol & Melitracen Tablets and control group with ganhuaidazao respectively for 4 weeks. The status of the patients was assessed before and after treatment with HAMD, TESS, Fourgrade clinical assessing criteria and the results of laboratory tests to compare the therapeutic ef icacy and side effects of Flupentixol & Melitracen Tablets with ganhuaidazao. Results The total ef ective rate was 82.25% in therapy group and 54.83% in control group respectively. Significant dif erence was found between two groups. The incidence of side ef ects in therapy group was 2.01%,but no evident side ef ects was found in control group. Conclusion The therapeutic ef icacy of Flupentixol & Melitracen Tablets for somatization disorder is significant with less side ef ects.
